Natixis Investment Managers International Illumina, Inc. Transaction History

Natixis Investment Managers International

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $223,524 - $453,008	1,231 Added 92.98%	2,555 $471,000
Q1 2022 May 13, 2022	BUY	$303.87 - $423.8 $402,323 - $561,111	1,324 New	1,324 $462,000
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $7.28 Million - $9.79 Million	-26,712 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $1.6 Million - $2.11 Million	5,741 Added 27.38%	26,712 $9.8 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $614,233 - $786,252	2,692 Added 14.73%	20,971 $5.86 Million
Q1 2018 May 15, 2018	BUY	$209.54 - $253.91 $2.63 Million - $3.19 Million	12,552 Added 219.17%	18,279 $4.32 Million
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $4,824 - $5,990	28 Added 0.49%	5,727 $1.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,699	5,699 $989,000

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.